EMA report on CAR T-cell therapies workshop

This report summarises observations made by the participants of the workshop organised by the EMA on February 9th 2018 on the use of registry data to support regulatory benefit-risk evaluations of CAR T-cell therapies and, in particular, post-authorisation follow-up.